Euclidean Capital as of March 31, 2023
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 10 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ishares Tr Msci India Etf (INDA) | 41.4 | $47M | 1.2M | 39.36 | |
| 23andme Holding Class A Com | 20.5 | $23M | 10M | 2.28 | |
| Pmv Pharmaceuticals (PMVP) | 9.8 | $11M | 2.3M | 4.77 | |
| Rapt Therapeutics | 7.0 | $7.9M | 433k | 18.35 | |
| Foghorn Therapeutics (FHTX) | 6.9 | $7.8M | 1.3M | 6.20 | |
| Alector (ALEC) | 5.3 | $6.1M | 981k | 6.19 | |
| Oric Pharmaceuticals (ORIC) | 3.7 | $4.3M | 748k | 5.70 | |
| Ngm Biopharmaceuticals | 2.7 | $3.0M | 747k | 4.08 | |
| Tenaya Therapeutics (TNYA) | 2.3 | $2.6M | 916k | 2.85 | |
| Surrozen | 0.4 | $483k | 803k | 0.60 |
